Source:http://linkedlifedata.com/resource/pubmed/id/21444793
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2011-4-13
|
pubmed:abstractText |
Cytokine immunotherapies targeting T lymphocytes are attractive clinical interventions against viruses and tumors. In the mouse, the homeostasis of memory ?/? CD8(+) T cells and natural killer (NK) cells is significantly improved with increased IL-15 bioavailability. In contrast, the role of "transpresented" IL-15 on human T-cell development and homeostasis in vivo is unknown. We found that both CD8 and CD4 T cells in human immune system (HIS) mice are highly sensitive to transpresented IL-15 in vivo, with both naïve (CD62L(+)CD45RA(+)) and memory phenotype (CD62L(-)CD45RO(+)) subsets being significantly increased following IL-15 "boosting." The unexpected global improvement in human T-cell homeostasis involved enhanced proliferation and survival of both naïve and memory phenotype peripheral T cells, which potentiated B-cell responses by increasing the frequency of antigen-specific responses following immunization. Transpresented IL-15 did not modify T-cell activation patterns or alter the global T-cell receptor (TCR) repertoire diversity. Our results indicate an unexpected effect of IL-15 on human T cells in vivo, in particular on CD4(+) T cells. As IL-15 promotes human peripheral T-cell homeostasis and increases the frequency of neutralizing antibody responses in HIS mice, IL-15 immunotherapy could be envisaged as a unique approach to improve vaccine responses in the clinical setting.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1091-6490
|
pubmed:author |
pubmed-author:AlvesNuno LNL,
pubmed-author:BeckerPablo DPD,
pubmed-author:Di SantoJames PJP,
pubmed-author:GuzmanCarlosC,
pubmed-author:HuntingtonNicholas DND,
pubmed-author:JacquesYannickY,
pubmed-author:KremsdorfDinaD,
pubmed-author:LegrandNicolasN,
pubmed-author:LimAnnickA,
pubmed-author:MentionJean-JacquesJJ,
pubmed-author:PletArianeA,
pubmed-author:SoussanPatrickP,
pubmed-author:SpitsHergenH,
pubmed-author:Strick-MarchandHeleneH,
pubmed-author:WeijerKeesK
|
pubmed:issnType |
Electronic
|
pubmed:day |
12
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6217-22
|
pubmed:dateRevised |
2011-10-12
|
pubmed:meshHeading |
pubmed-meshheading:21444793-Animals,
pubmed-meshheading:21444793-Antibody Formation,
pubmed-meshheading:21444793-CD4-Positive T-Lymphocytes,
pubmed-meshheading:21444793-CD8-Positive T-Lymphocytes,
pubmed-meshheading:21444793-Cell Proliferation,
pubmed-meshheading:21444793-Humans,
pubmed-meshheading:21444793-Interleukin-15,
pubmed-meshheading:21444793-Mice,
pubmed-meshheading:21444793-Mice, Mutant Strains,
pubmed-meshheading:21444793-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:21444793-Receptors, Interleukin-15
|
pubmed:year |
2011
|
pubmed:articleTitle |
IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo.
|
pubmed:affiliation |
Innate Immunity Unit, Immunology Department, Institut Pasteur, 75724 Paris, France. nhunting@pasteur.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|